Ergosterol-containing cell membrane

The ergosterol-containing cell membrane is a critical structural component of fungi and certain protozoa, serving as the primary barrier between the cytoplasm and the external environment (Source: StatPearls, NBK532283). Ergosterol, a sterol unique to these organisms, plays a vital role in maintaining membrane fluidity, integrity, and the function of membrane-bound enzymes, serving a purpose analogous to cholesterol in mammalian cells (Source: PubMed, PMID: 29124368). This membrane is a major therapeutic target for polyene antibiotics, such as amphotericin B and nystatin, which exploit the presence of ergosterol to achieve selective toxicity. When these drugs bind to ergosterol, they disrupt the lipid bilayer by forming aqueous pores or through surface adsorption, leading to lethal ion leakage and oxidative damage (Source: Wikipedia, Polyene antimycotic). Because human cell membranes contain cholesterol instead of ergosterol, these drugs are selectively toxic to pathogens, although high doses can lead to side effects due to limited cross-reactivity with host sterols. Targeting this membrane remains a cornerstone in treating systemic fungal infections and certain parasitic diseases like leishmaniasis (Source: NIH, National Institute of Allergy and Infectious Diseases).

Other names

Fungal cell membraneProtozoan cell membraneErgosterol-rich lipid bilayer

Polyene antimycotics bind specifically to ergosterol within the cell membrane, leading to the formation of transmembrane pores (Source: StatPearls, NBK532283). These pores cause the rapid leakage of essential intracellular ions, such as potassium, and small molecules, resulting in osmotic instability and cell death. Additionally, recent research suggests a "sterol sponge" mechanism where the drug aggregates and extracts ergosterol directly from the lipid bilayer, disrupting membrane-associated protein functions (Source: PubMed, PMID: 24625922).